Femto Medicine - Part 5162

Mini Powder Mixer, Powder Blender For Use in R D/ Nutritional Supplements/ Pharmacy Compounding Company: CapsulCN LLC Web: store.capsulcn.com Tel: 0086-15967727000 Email: capsulcn.sale@gmail.com Description: Perfect size to blend powder for a batch of 3... By: CAPSULCNLLC … Continue reading →

Posted in Pharmacy | Comments Off

CVS Caremark Receives URAC Accreditation in Specialty Pharmacy

Posted: Published on June 12th, 2013

WOONSOCKET, R.I., June 11, 2013 /PRNewswire/ --CVS Caremark (CVS) announced today that it has been awarded Specialty Pharmacy accreditation from URAC, a Washington, DC-based health care accrediting organization that establishes quality standards for the health care industry. (Logo: http://photos.prnewswire.com/prnh/20090226/NE75914LOGO) "Specialty Pharmacy is a critical component of pharmacy care services offered by CVS Caremark," said EVP of Specialty Pharmacy, Alan Lotvin, M.D.. "We aspire to provide the highest level of quality services to patients who need specialty medications and this accreditation is testimony to our ability to deliver on this goal." CVS Caremark Specialty Pharmacy is focused on providing drug therapy management and dispensing services for patients requiring treatment with medications that are used to treat rare, chronic or genetic conditions. CVS Caremark provides specialty patients with support and counseling to help them manage their specialty medications to ensure appropriate and safe medication use and optimize positive outcomes. Services also include ongoing disease education and therapy counseling, benefits verification, coordination of care with multiple health care providers, comprehensive patient education and adherence management. "We applaud CVS Caremark on achieving URAC Specialty Pharmacy accreditation," said William Vandervennet, URAC Chief Operating Officer. "In today's health care market, URAC accreditation provides a mark of … Continue reading →

Posted in Pharmacy | Comments Off

Guild congratulates Community Pharmacy of the Year winner

Posted: Published on June 12th, 2013

The Pharmacy Guild of New Zealand (the Guild) congratulates David Postlewaight, owner of Davids Pharmacy in Kamo, for winning the Community Pharmacy of the Year Award at the 2013 Pharmacy Awards, held at the Langham Hotel in Auckland on Saturday 8 June. Guild Chief Executive, Lee Hohaia, believes the success of Guild members at this years Pharmacy Awards reflects the high quality of service provided by member pharmacies. "The high number of Guild pharmacies represented among the finalists indicates the excellent care that our members are providing to their communities", Mrs Hohaia says. This year, for the first time, the award was given to the pharmacy that was ranked the highest by its patients. More than 18,000 patients from 253 community pharmacies completed and returned an extensive user satisfaction survey. Using the response to how the question: "How likely is it that you would recommend this pharmacy to a friend or colleague?" a net promoter score was generated for each pharmacy. A net promoter score is a measure of customer loyalty. It can be as low as 100 or as high as +100. A net promoter score of +50 is considered excellent. "Across all participating pharmacies, the net promoter score … Continue reading →

Posted in Pharmacy | Comments Off

DR Elias Abdo Aesthetic Surgery – Lebanon – Video

Posted: Published on June 11th, 2013

DR Elias Abdo Aesthetic Surgery - Lebanon DR Elias Abdo Aesthetic Surgery - Lebanon. By: Mohammad Rizk … Continue reading →

Posted in Aesthetic Surgery | Comments Off

CTI Announces Data Presentations at the 18th Congress of the European Hematology Association

Posted: Published on June 11th, 2013

SEATTLE, June 11, 2013 /PRNewswire/ -- Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today announced the upcoming presentation of data highlighting PIXUVRI (pixantrone), the first approved treatment in the European Union for aggressive B-cell non-Hodgkin lymphoma (NHL) for adult patients who have failed 2 to 3 prior lines of therapy, and results from a pooled analysis of data from completed Phase 1 and 2 studies of pacritinib, a novel, oral JAK2/FLT3 inhibitor, at the 18th Congress of the European Hematology Association (EHA) Annual Meeting, June 13-16, 2013 in Stockholm, Sweden. "At EHA, we plan to present further analyses of the final safety and efficacy data from our EXTEND pivotal trial of PIXUVRI that we believe expand our understanding of the potential clinical benefit for patients with aggressive B-cell NHL who had received 2 to 3 prior regimens," said Jack Singer, M.D., Executive Vice President, Global Medical Affairs and Translational Medicine at CTI. "In addition, at EHA, results from a pooled integrated safety analysis from four Phase 1 and 2 clinical trials will be presented that quantify clinical toxicities of pacritinib, our novel, oral JAK2/FLT3 inhibitor currently being investigated in a Phase 3 clinical program." Information regarding the EHA presentations … Continue reading →

Posted in FDA Stem Cell Trials | Comments Off

Leonhardt Ventures Chooses CORE Manufacturing to Develop and Produce Next-Generation Pacemakers and Stem Cell Pump

Posted: Published on June 11th, 2013

SANTA MONICA, Calif., June 11, 2013 /PRNewswire/ --Leonhardt Ventures and CORE Manufacturing, LLC, are pleased to announce a new partnership. Leonhardt Ventures has partnered with CORE Manufacturing to manufacture and bring to market a lineup of breakthrough medical technologies, including: CORE Manufacturing is a relatively new entity in a long-standing active implantable device cGMP manufacturing facility. While the entity is new, the CORE Manufacturing team has active implantable device development and manufacturing experience dating back to the 1970s. Under the new agreement, CORE Manufacturing will provide world-class manufacturing services for active implantable devices on behalf of Leonhardt Ventures' portfolio of companies and developments. CORE Manufacturing is a unique resource for OEMs looking for commercialization of complex medical devices, with capabilities that include rapid-turn prototyping and full turnkey device-level assembly, sterilization and testing, specializing in active implantable devices. The combination of CORE Manufacturing's world-class assembly and test capability with CIRTEC's advanced active implant design, development and pilot manufacturing enables Leonhardt Ventures' portfolio companies to leverage the most sophisticated, single-stop outsource solution for bringing their active implantable devices to market safely, without the enormous expense and risk of developing this capability internally. "We have long admired the team at CORE Manufacturing, as … Continue reading →

Posted in Stem Cell Human Trials | Comments Off

Part 21, after stem cell treatment, I don't recommend it, 08June2013 – Video

Posted: Published on June 11th, 2013

Part 21, after stem cell treatment, I don't recommend it, 08June2013 My name is Carole St-Laurent, I am from Rimouski, Quebec, Canada. I have a Spinal Muscular Atrophy from birth, it's in the family of Muscular Dystrophy. I re... By: Kina Diamond … Continue reading →

Comments Off

Page 5,162«..10 20..5,1615,1625,163 5,164..5,170 5,180..»

Pharmacy Futsal Community – FA 2012 Part 18 – Video

Pharmacy Futsal Community – FA 2012 Part 22 – Video

Pharmacy Futsal Community – FA 2012 Part 21 – Video

Mini Powder Mixer, Powder Blender For Use in R

CVS Caremark Receives URAC Accreditation in Specialty Pharmacy

Guild congratulates Community Pharmacy of the Year winner

DR Elias Abdo Aesthetic Surgery – Lebanon – Video

CTI Announces Data Presentations at the 18th Congress of the European Hematology Association

Leonhardt Ventures Chooses CORE Manufacturing to Develop and Produce Next-Generation Pacemakers and Stem Cell Pump

Part 21, after stem cell treatment, I don't recommend it, 08June2013 – Video

Categories

Archives